Lv4
506 积分 2022-06-12 加入
Replication stress in cancer: origins, consequences and therapeutic opportunities
5天前
已完结
The evolving landscape of drug targets
6天前
已完结
Navigating the clinical progress of antibody-drug conjugates: Emerging opportunities and remaining challenges
21天前
已完结
Lessons from drug revenue life cycles: distributions across modalities and therapeutic areas
24天前
已完结
Global cancer statistics 2024: translating epidemiological trends into priorities for healthcare systems
1个月前
已完结
Re-evaluating antibody–drug conjugate linker stability: assessment, interpretation, and clinical translation
1个月前
已完结
The Next Generation of Antibody Drug Conjugates
2个月前
已完结
Two decades of PARP inhibitor synthetic lethality in cancer
2个月前
已完结
RHINO directs MMEJ to repair DNA breaks in mitosis
2个月前
已完结
Cancer burden and control in China: landscape, trends and challenges
2个月前
已完结
皖公网安备34019202002308
